Fig. 1From: Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case seriesDigital photography of left chest wall disease for patient 2 before treatment (left) and after the first course of radiation and combination therapy (right), demonstrating dramatic improvement in skin diseaseBack to article page